Eli Lilly and Company (LLY) News Today $807.42 -11.51 (-1.41%) (As of 03:09 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Eli Lilly and Company (NYSE:LLY) Stock Price Down 1.2% After Analyst DowngradeEli Lilly and Company (NYSE:LLY) Shares Down 1.2% After Analyst DowngradeNovember 4 at 2:55 PM | marketbeat.comEli Lilly and Company (NYSE:LLY) Price Target Cut to $1,015.00 by Analysts at Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft reduced their price target on Eli Lilly and Company from $1,025.00 to $1,015.00 and set a "buy" rating for the company in a report on Monday.November 4 at 1:48 PM | marketbeat.comQRG Capital Management Inc. Buys 1,980 Shares of Eli Lilly and Company (NYSE:LLY)QRG Capital Management Inc. boosted its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 1.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,162 shares of the company's stock after buyinNovember 4 at 9:57 AM | marketbeat.comBig Pharma's Obesity Bonanza Faces New TestsNovember 4 at 8:14 AM | wsj.comEli Lilly and Company Q3 Earnings TranscriptNovember 4 at 7:10 AM | marketbeat.comThis Pharma Stock Is Soaring 21%. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo.November 4 at 6:27 AM | barrons.comKFSHRC & Lilly Collaborate in Alzheimer's Early DetectionNovember 3 at 10:37 AM | globenewswire.comVan ECK Associates Corp Increases Stock Holdings in Eli Lilly and Company (NYSE:LLY)Van ECK Associates Corp raised its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 11.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 269,469 shares of the company's stock after purchasing an additionalNovember 3 at 10:04 AM | marketbeat.comCould This Near Trillion-Dollar Stock Be a Millionaire Maker?November 3 at 9:45 AM | fool.comLeerink Partnrs Has Negative Outlook of LLY FY2024 EarningsNovember 3 at 2:07 AM | americanbankingnews.comEli Lilly and Company Just Missed Earnings - But Analysts Have Updated Their ModelsNovember 3 at 12:19 AM | finance.yahoo.comF M Investments LLC Sells 2,330 Shares of Eli Lilly and Company (NYSE:LLY)F M Investments LLC trimmed its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 4.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 45,181 shares of the company's stock after selling 2,330 sharesNovember 2 at 10:05 AM | marketbeat.comLilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from Its Breast Cancer Portfolio at the San Antonio Breast Cancer SymposiumNovember 1 at 5:30 PM | prnewswire.comEli Lilly and Company (NYSE:LLY) Stock Price Down 0.7% After Analyst DowngradeEli Lilly and Company (NYSE:LLY) Shares Down 0.7% Following Analyst DowngradeNovember 1 at 11:15 AM | marketbeat.comPrincipal Securities Inc. Purchases 1,027 Shares of Eli Lilly and Company (NYSE:LLY)Principal Securities Inc. raised its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 7.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,189 shares of the company's stock after acquiring an addNovember 1 at 9:02 AM | marketbeat.comHere Are the Next 3 Stock Splits to Keep on Your RadarNovember 1 at 8:11 AM | 247wallst.comLeerink Partnrs Issues Pessimistic Forecast for LLY EarningsEli Lilly and Company (NYSE:LLY - Free Report) - Research analysts at Leerink Partnrs dropped their FY2024 EPS estimates for Eli Lilly and Company in a research note issued to investors on Thursday, October 31st. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earniNovember 1 at 7:45 AM | marketbeat.comEli Lilly & Co: Buy Rating Affirmed Amidst U.S. Market Challenges and International Growth PotentialNovember 1 at 5:54 AM | markets.businessinsider.comEli Lilly Earnings Have Wall Street Asking New Questions About GLP-1 Drugs. Is Something Going Wrong?November 1 at 5:54 AM | msn.comKnockoff weight loss drugs are having a moment. Eli Lilly isn't worriedOctober 31, 2024 | yahoo.comBarclays Lowers Eli Lilly and Company (NYSE:LLY) Price Target to $975.00Barclays decreased their price target on shares of Eli Lilly and Company from $1,025.00 to $975.00 and set an "overweight" rating on the stock in a research note on Thursday.October 31, 2024 | marketbeat.comEli Lilly viewed positively despite Mounjaro, Zepbound disappointment - BoAOctober 31, 2024 | proactiveinvestors.comEli Lilly Earnings Have Wall Street Jittery on Zepbound Sales. What Comes Next.October 31, 2024 | barrons.comEli Lilly and Company (NYSE:LLY) Stock Price Down 1.9% After Earnings MissEli Lilly and Company (NYSE:LLY) Shares Down 1.9% After Earnings MissOctober 31, 2024 | marketbeat.comNasdaq edges back from its record as chip companies and Eli Lilly slumpOctober 31, 2024 | msn.comEli Lilly Shares Hit Yearly Low After Disappointing Q3 EarningsOctober 31, 2024 | gurufocus.comBurr Financial Services LLC Increases Stake in Eli Lilly and Company (NYSE:LLY)Burr Financial Services LLC increased its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 50.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,806 shares of the compaOctober 31, 2024 | marketbeat.comViking Therapeutics Stock: A Pre-Election Bet Worth Considering (LLY)Viking Therapeutics is making headway in the weight loss drug market; but even though the payoff is years away, there's still plenty of upside for investorsOctober 31, 2024 | marketbeat.comMidday stock movers: Alphabet, Super Micro, Eli Lilly and moreOctober 31, 2024 | msn.comEli Lilly’s third quarter earnings miss and forecast cut lead to sharp stock dropOctober 31, 2024 | msn.comAre Eli Lilly's Lowered Expectations a Reason to Sell?October 31, 2024 | fool.comEli Lilly and Company (NYSE:LLY) Shares Gap Down on Disappointing EarningsOctober 31, 2024 | americanbankingnews.comEli Lilly and Company (NYSE:LLY) Shares Down 6% Following Weak EarningsOctober 31, 2024 | americanbankingnews.comStock market today: Asia shares decline as investors await earnings, US elections and economic dataAsian shares are mostly declining amid uncertainty ahead of the United States presidential election next weekOctober 30, 2024 | marketbeat.comHow major US stock indexes fared Wednesday, 10/30/2024U.S. stock indexes gave up an early gain and ended slightly lower following a mixed set of profit reports from giants like Google’s parent company and Eli LillyOctober 30, 2024 | marketbeat.comWhat You May Have Missed From Eli Lilly's Q3 2024 Earnings DisappointmentOctober 30, 2024 | seekingalpha.comEli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell shortOctober 30, 2024 | cnbc.comEli Lilly: The Stock Might Have PeakedOctober 30, 2024 | seekingalpha.comEli Lilly’s stock tumbles as obesity drug sales miss expectations by wide marginOctober 30, 2024 | marketwatch.comWhy Eli Lilly Stock Is Sinking TodayOctober 30, 2024 | fool.comEli Lilly and Company (NYSE:LLY) Trading Down 6% After Earnings MissEli Lilly and Company (NYSE:LLY) Shares Down 6% After Earnings MissOctober 30, 2024 | marketbeat.comEli Lilly and Company (NYSE:LLY) Updates FY24 Earnings GuidanceEli Lilly and Company (NYSE:LLY) updated its FY24 earnings guidance. The company provided EPS guidance of $13.02-13.52 for the period, compared to the consensus estimate of $13.42. The company also issued revenue guidance of $45.4-46.0 billionillion, compared to the consensus estimate of $46.24 billionillion.October 30, 2024 | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Gap Down Following Weak EarningsEli Lilly and Company (NYSE:LLY) Shares Gap Down on Disappointing EarningsOctober 30, 2024 | marketbeat.comEli Lilly tumbles as weight loss drug sales underwhelm, guidance slashedOctober 30, 2024 | proactiveinvestors.comDrugmaker Eli Lilly walks back 2024 forecast after 3Q earnings missEli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectationsOctober 30, 2024 | marketbeat.comEli Lilly and Company (NYSE:LLY) Releases Quarterly Earnings Results, Misses Expectations By $0.35 EPSEli Lilly and Company (NYSE:LLY - Get Free Report) issued its earnings results on Wednesday. The company reported $1.18 EPS for the quarter, missing the consensus estimate of $1.53 by ($0.35). The firm had revenue of $11.44 billion during the quarter, compared to analyst estimates of $12.09 billion. Eli Lilly and Company had a net margin of 18.86% and a return on equity of 67.52%. Eli Lilly and Company's quarterly revenue was up 20.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.10 earnings per share.October 30, 2024 | marketbeat.comEli Lilly misses quarterly estimates as manufacturing costs riseOctober 30, 2024 | ft.comEli Lilly Misses Quarterly Profit Estimates; Shares TumbleOctober 30, 2024 | msn.comEli Lilly Stock Tumbles as Q3 Sales, Profits Fall Well Short of EstimatesOctober 30, 2024 | investopedia.comEli Lilly Dives On Earnings Miss As Diabetes, Weight-Loss Drugs Fall ShortOctober 30, 2024 | investors.com Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address How high could Bitcoin go? (Ad)Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.” Learn More Here LLY Media Mentions By Week LLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LLY News Sentiment▼0.070.46▲Average Medical News Sentiment LLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LLY Articles This Week▼8442▲LLY Articles Average Week Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Bristol-Myers Squibb News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:LLY) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredCentral banks prepare for America’s Breaking PointIf you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.